iXensor Co. Ltd. announces that it received the approval of CE mark in July, 2014. The approval of CE mark for the self-monitoring glucose system, PixoTest and its smartphone app, PixoHealth, is significant for initiating market in Europe by the end of 2014. iXensor aims to introduce the simpler way of testing blood glucose for self controlling and management of diabetes.
The compact system allows the patient to carry only his smartphone and sufficient test units for his daily needs. The PixoTest™ app records and analyzes the measurements which are available at any time through the app or from the Cloud. iXensor plans on expanding into other tests such as Cholestrol, uric acid and cardiac enzymes.